Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Metabolic Syndrome 1Lymphoma, Non-Hodgkin 1Heart Failure 1Cardiovascular Diseases 1Cardiotoxicity 1Cardiomyopathies 1

Interventions

Doxorubicin 6Vincristine 4Dexrazoxane 4Razoxane 3Radiotherapy 2Prednisone 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Exercise 2Etoposide 2Cyclophosphamide 2Bleomycin 2pegfilgrastim 1hydrocortisone hemisuccinate 1Vascular Stiffness 1VAP-cyclo protocol 1Secondary Prevention 1Rituximab 1Pulse Wave Analysis 1Prednisolone 1Nebivolol 1Methotrexate 1Methods 1Mercaptopurine 1Leucovorin 1Lenalidomide 1Hydrocortisone 1Electrocardiography 1Echocardiography 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cardiotoxicity × Pulse Wave Analysis × Lymphoid × Clear all
NCT07041827 2025-06-27

CLARITY

The Netherlands Cancer Institute

Completed
217 enrolled
Lymphoid

Cardiovascular Diseases, Heart Failure, Lymphoma, Non-Hodgkin, Cardiomyopathies, Metabolic Syndrome, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡